Rhythm Pharmaceuticals Stock Forecast

Stock Price Forecast

The 12 analysts with 12-month price forecasts for Rhythm Pharmaceuticals stock have an average target of 68.58, with a low estimate of 52 and a high estimate of 81. The average target predicts an increase of 29.56% from the current stock price of 52.94.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$52	$68.58	$70	$81
Change	-1.77%	+29.56%	+32.24%	+53.02%

Analyst Ratings

The average analyst rating for Rhythm Pharmaceuticals stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	5	6	6	6	6	7
Buy	3	3	3	3	3	4
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	10	10	10	10	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $70	Strong Buy	Reiterates	$70	+32.24%	Mar 24, 2025
Joseph Stringer Needham	Needham	Strong Buy Maintains $64 → $66	Strong Buy	Maintains	$64 → $66	+24.68%	Mar 18, 2025
Jeffrey Hung Morgan Stanley	Morgan Stanley	Buy Initiates $72	Buy	Initiates	$72	+36.02%	Mar 7, 2025
Paul Matteis Stifel	Stifel	Strong Buy Initiates $78	Strong Buy	Initiates	$78	+47.35%	Mar 5, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $69 → $70	Strong Buy	Maintains	$69 → $70	+32.24%	Mar 3, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

189.28M

from 130.13M

45.46%

from 130.13M

Revenue Next Year

308.61M

from 189.28M

63.04%

from 189.28M

EPS This Year

-2.59

from -4.34

EPS Next Year

-1.27

from -2.59

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	3.15M	23.64M	77.43M	130.13M	189.28M	308.61M	560.45M
Revenue Growth	-	-	649.46%	227.56%	68.06%	45.46%	63.04%	81.60%
EPS	-3.04	-1.40	-3.47	-3.20	-4.34	-2.59	-1.27	1.92
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	27.50
No. Analysts	-	-	-	-	-	14	14	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	208.1M	420.0M	686.8M
Avg	189.3M	308.6M	560.5M
Low	174.4M	245.5M	398.9M

Revenue Growth

Revenue Growth	2025	2026	2027
High	59.9%	121.9%	122.5%
Avg	45.5%	63.0%	81.6%
Low	34.1%	29.7%	29.2%

EPS Forecast

EPS	2025	2026	2027
High	-2.06	-0.40	3.49
Avg	-2.59	-1.27	1.92
Low	-3.09	-2.38	-0.20

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.